Acció Talk Participation

September 1, 2020

Within the framework of International R&D Nuclis call organized by ACCIÓ, Cytes Biotechnologies has been chosen as a success case for having won the grant that will promote its expansion and international growth.

For this reason, Jordi Xapelli, CEO of Cytes Biotechnologies, SL participated in a talk that took place last Friday, July 17th, where he explained the progress of the project in which the company is involved within this framework.

The aim of this talk was to promote the realization of R+D activities carried out in Catalonia and to facilitate international technological cooperation with foreign entities.

More News 

Maria Jesus Lozano Incorporation

Maria Jesus Lozano Incorporation

October 9, 2020

From Cytes Biotechnologies, SL, we are pleased to announce a new internship incorporation.

Read More

3D Spheroid Qualified at 2D Price! (Second Promotion)

3D Spheroid Qualified at 2D Price! (Second Promotion)

September 15, 2020

We are happy to announce that we have 3D Spheroid qualified Hepatocytes available at 2D price until Desember 31th! 

Read More

Robert Gobern Incorporation

Robert Gobern Incorporation

September 9, 2020

From Cytes Biotechnologies, SL, we are pleased to announce a new job incorporation.

Read More

Eduardo Chueca Incorporation

Eduardo Chueca Incorporation

September 2, 2020

From Cytes Biotechnologies, SL, we are pleased to announce a new job incorporation.

Read More